IRIS Accounts Production v25.1.4.42 04578100 Board of Directors 1.6.23 31.5.24 31.5.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh045781002023-05-31045781002024-05-31045781002023-06-012024-05-31045781002022-05-31045781002022-06-012023-05-31045781002023-05-3104578100ns15:EnglandWales2023-06-012024-05-3104578100ns14:PoundSterling2023-06-012024-05-3104578100ns10:Director12023-06-012024-05-3104578100ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3104578100ns10:SmallEntities2023-06-012024-05-3104578100ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3104578100ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3104578100ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3104578100ns10:FullAccounts2023-06-012024-05-3104578100ns10:Director22023-06-012024-05-3104578100ns10:Director32023-06-012024-05-3104578100ns10:Director42023-06-012024-05-3104578100ns10:RegisteredOffice2023-06-012024-05-3104578100ns5:ShareCapital2024-05-3104578100ns5:ShareCapital2023-05-31
REGISTERED NUMBER: 04578100 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 May 2024

for

Surescreen Life Sciences Limited

Surescreen Life Sciences Limited (Registered number: 04578100)






Contents of the Financial Statements
for the Year Ended 31 May 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Surescreen Life Sciences Limited

Company Information
for the Year Ended 31 May 2024







DIRECTORS: J G Campbell
D S Campbell
A R Campbell
A J Campbell





REGISTERED OFFICE: 17 Eagle Park
Alfreton Road
Derby
Derbyshire
DE21 4BF





REGISTERED NUMBER: 04578100 (England and Wales)





ACCOUNTANTS: Bates Weston LLP
Chartered Accountants
The Mills
Canal Street
Derby
DE1 2RJ

Surescreen Life Sciences Limited (Registered number: 04578100)

Balance Sheet
31 May 2024

2024 2023
£    £   
CURRENT ASSETS
Cash at bank 2 2
TOTAL ASSETS LESS CURRENT
LIABILITIES

2

2

CAPITAL AND RESERVES
Called up share capital 2 2
SHAREHOLDERS' FUNDS 2 2

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 June 2025 and were signed on its behalf by:





D S Campbell - Director


Surescreen Life Sciences Limited (Registered number: 04578100)

Notes to the Financial Statements
for the Year Ended 31 May 2024

1. STATUTORY INFORMATION

Surescreen Life Sciences Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company was dormant throughout the current year and previous year.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. ULTIMATE PARENT COMPANY

The company's immediate parent undertaking is Surescreen Diagnostics Limited, and ultimate parent undertaking is Surescreen Holdings (2022) Limited, which prepares group financial statements. The registered office of both companies is 17 Eagle Park, Alfreton Road, Derby, DE21 4BF. Copies of the consolidated financial statements of Surescreen Holdings (2022) Limited are available from the Registrar of Companies, Companies House, Crown Way, Cardiff, CF14 3UZ.